Menu
1 min read · estimated
APPROVED USE
What FDA approved
An oral dasatinib tablet for adults with newly diagnosed chronic-phase Ph-positive CML, Ph-positive CML resistant or intolerant to prior therapy including imatinib across specified phases, or Ph-positive ALL resistant or intolerant to prior therapy.
LAMPGEN ANALYSIS
Why it matters
The approved presentation adds a dasatinib product with product-specific administration instructions.
What research teams should watch
Confirm the dispensed formulation and use its specific instructions for concomitant medicines, dose and administration.
PRIMARY RECORDS